Peiminine serves as an adriamycin chemosensitizer in gastric cancer by modulating the EGFR/FAK pathway

Qianqian Tang(Xinjiang Institute of Materia Medica), Zhengyi Gu(Xinjiang Institute of Materia Medica)
Oncology Reports
January 3, 2018
Cited by 23


Related Papers